Clinical Trials Browser

Phase 1/2 × NIH × resiniferatoxin × Clear all

NCT02522611 2026-06-01

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Phase 1/2 Not yet recruiting

Cancer Pain, Pain, Intractable